Stay updated on Seagen Press Releases

Sign up to get notified when there's something new on the Seagen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Seagen Press Releases page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    New June 2026 press releases were added to the list, including the dividend announcement, investor webcast, and topline trial results, while several May 2026 items were removed, updating the newsroom's current headlines.
    Difference
    9%
    Check dated 2026-06-28T08:26:33.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now adds a Leadership section with the Chief Financial Officer transition release (06.18.2026) and a Supplier & B2B Resources link. It also removes the ELREXFIO press release from April 2026 and its related category labels.
    Difference
    2%
    Check dated 2026-06-21T08:35:31.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A new HYMPAVZI press release appears under Medicines/Prescription Medicines dated 06.08.2026, and older Finance/Corporate categories and the VYNDAMAX settlement release (04.28.2026) are removed from the page.
    Difference
    2%
    Check dated 2026-06-14T06:53:04.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    June 2026 press releases were added to the Newsroom, including updates on Berobenatide Phase 2b, a webcast invitation, and a BRAFTOVI regimen update. Older April 2026 releases were removed.
    Difference
    10%
    Check dated 2026-06-07T02:23:43.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Four May 2026 press releases were added to the Newsroom, covering TALZENNA Plus XTANDI results in metastatic prostate cancer, LORBRENA CROWN trial results in advanced NSCLC, a global collaboration with Innovent Biologics to accelerate oncology medicines, and an investor webcast invitation.
    Difference
    8%
    Check dated 2026-05-30T20:36:54.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Adds a new press release entry titled 'Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results' dated 05.20.2026 under the Research and Pipeline category, expanding the page's current press listings. Removes 'Pfizer logo' and 'Finance' items from navigation/branding areas.
    Difference
    3%
    Check dated 2026-05-23T13:30:27.000Z thumbnail image

Stay in the know with updates to Seagen Press Releases

Enter your email address, and we'll notify you when there's something new on the Seagen Press Releases page.